**Abstract**

Nicotinic acetylcholine (nACh) receptors evoke convulsive seizures both in nicotine intoxication and human epileptic disorders (e.g., autosomal dominant nocturnal frontal lobe epilepsy \[ADNFLE\]). Here, we performed behavioral and immunohistochemical studies to elucidate the mechanisms of nicotine-induced seizures. Nicotine at high doses (4 mg/kg, i.p.) evoked convulsive seizures, which was antagonized by non-selective (mecamylamine) and α7-selective (methyllycaconitine) nACh receptor antagonists. Nicotine-induced seizures were accompanied by significant and region-specific increments in Fos protein expression, a biological marker of neural excitation, in the piriform cortex (Pir), amygdala (AMG), medial habenular nucleus (MHb), thalamus (Th) and solitary tract, suggesting that these regions are potential causative sites for nicotine-induced seizures. Electrical lesioning (1 mA for 15 sec per side) of AMG significantly suppressed nicotine-induced seizures, whereas neither lesioning of the Pir, MHb nor Th affected the nicotine seizure induction. Furthermore, bilateral microinjection of nicotine (100 or 300 μg/μL/side) into the AMG effectively evoked convulsive seizure in a dose-dependent manner. The present results strongly suggest that acute nicotine treatment evokes convulsive seizures by activating amygdala neurons, mainly through α7nACh receptors.
